All In MedTech

FDA Clearance Tracker · P050020-S022

FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 14, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 14, 2011

Approved

Time to decision

346 days

Received Feb 2, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P050020-S022
Device name
FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEM
Applicant location
Alameda, CA
Received
Feb 2, 2010
Decided
Jan 14, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Original approval
P050020

Device type

Device class
Class III

Every decision under product code MDS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR CHANGES TO THE OUTGOING QUALITY CONTROL (QC) SOLUTION TESTING.

Source documents

Other decisions for Abbott Laboratories

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.